Since the blow up behind the CBD industry has erupted, the new trendy fad of CBD-infused food and drinks have hit restaurants and markets across the country. The idea and market for edibles have always been around; however, since the legalization of CBD, it has caused a large controversial debate among the FDA.
Tuesday, The Food and Drug Administration has announced its first public hearing to legalize CBD additives in food and drink, to detail how they will regulate the cannabis products. The conference is said to take place on May 31st.
According to the announcement, the agency would require data on CBD’s safety in food products and feedback on how it might regulate the manufacturing, marketing, and labeling. The now-former FDA Commissioner Scott Gottlieb appointed Principal Deputy Commissioner Amy Abernethy and Principal Associate Commissioner for Policy Lowell Schiller to co-chair a high-level working group tasked with controlling the issue as well as evaluating the process.
“It’s critical that we address these unanswered questions about CBD and other cannabis and cannabis-derived products to help inform the FDA’s regulatory oversight of these products — especially as the agency considers whether it could be appropriate to exercise its authority to allow the use of CBD in dietary supplements and other foods,” Gottlieb announced in a statement Tuesday.
The famous compound CBD, is short for cannabidiol, is a non-psychoactive compound found in marijuana that promotes relaxation throughout the body without inducing mind altering effects-like THC would. Recently, Congress legalized CBD within the Farm bill in December 2018.
Many thought the huge step would lead to a flooded market of products infused with the marijuana compound. Although, the FDA’s rules prohibit any company from adding any CBD to food and drinks. This regulation has kicked many companies to the curb and kept many at a standstill; however, regardless of the rules, various start-up companies have still launched with the hopes the regulations would change.
With the backlash and pressure from Congress, the FDA has been privately searching for a fix, and now is taking it public. The first meeting which is being held at the headquarters near Washington, D.C., according to Gottlieb the working team hopes to announce its discoveries as soon as June.
“This is a complicated topic, and we expect that it could take some time to resolve fully,” he said. “Nevertheless, we’re deeply focused on this issue and committed to continuing to engage relevant stakeholders as we consider potential paths forward.”
Reports from the FDA and Federal Trade Commission stated that on Tuesday it had issued warning letters to three primary companies-Advanced Spine and Pain’s Relievus, Nutra Pure and PotNetwork Holdings- for making unsupported or “unproven” claims about their CBD product lines, descriptions detailing things like, ” Our products help in treating cancer and Alzheimer’s disease.”
“The FDA continues to be concerned about the proliferation of egregious medical claims being made about products asserting to contain CBD that hasn’t been approved by the FDA, such as the products and companies receiving warning letters today,” Gottlieb said.
According to a statement given by Nutra Pure President CJ Montgomery to CNBC explained that compared with “many other CBD-related companies making over-the-top health claims,” the language his company used was “quite minor.” He also added that the company has currently removed all content about such language, “out of an abundance of caution” yet is still, “seeking affirmation from the FDA on the few remaining issues.”
The FDA has not released any more information regarding the hearing.
If someone is looking for treatment for prescription drug abuse or mental illness close to home, search “Drug Rehab New Jersey “and use the directory to find a center. For more information, please call our 24-hour hotline, CALL (888) 510-3898
The Recover is an unbiased substance abuse and mental health news provider. Helping individuals looking for the right treatment programs in their area. Also providing information on drug rehab centers for addiction recovery.
Contact: Kennedy Adams
Company: The Recover
Address: Huntington Beach, CA
Contact Number: (888) 510-3898
Email: info@therecover.com
Website: www.therecover.com
Access to top treatment centers
Caring, supportive guidance
Financial assistance options
